Previous Article | Next Article 
Infection and Immunity, August 2001, p. 5025-5030, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.5025-5030.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Differential Roles of Interleukin-18 (IL-18) and IL-12 for
Induction of Gamma Interferon by Staphylococcal Cell Wall
Components and Superantigens
Rogier J. L.
Stuyt,1,2
Mihai G.
Netea,1,2,*
Soo-Hyun
Kim,1
Daniela
Novick,3
Menachem
Rubinstein,3
Bart-Jan
Kullberg,2
Jos W. M.
Van
der Meer,2 and
Charles A.
Dinarello1
Department of Medicine, University of
Colorado Health Sciences Center, Denver,
Colorado1; Department of Medicine,
University Medical Center St. Radboud, Nijmegen, The
Netherlands2; and Department of
Molecular Genetics, Weizmann Institute of Science, Rehovot,
Israel3
Received 20 February 2001/Returned for modification 26 March
2001/Accepted 16 May 2001
 |
ABSTRACT |
The roles of endogenous cytokines induced by either intact
staphylococcal microorganisms or staphylococcal exotoxins were examined
using human whole-blood cultures. To accomplish this, interleukin-18
binding protein (IL-18BP) and tumor necrosis factor binding protein
(TNFbp) were used to neutralize IL-18 and TNF, respectively, whereas an
anti-IL-12 monoclonal antibody was used to neutralize IL-12 and the
IL-1 receptor antagonist (IL-1Ra) was used to block IL-1 receptors.
Heat-killed Staphylococcus epidermidis and
Staphylococcus aureus, as well as the staphylococcal
superantigens toxic shock syndrome toxin-1 (TSST-1) and staphylococcus
enterotoxin B (SEB) induced gamma interferon (IFN-
) production.
Staphylococcus spp.-induced production of IFN-
required
the presence of endogenous IL-18, IL-12, and TNF. In contrast,
TSST-1-induced IFN-
was not significantly reduced in the presence of
IL-18BP, anti-IL-12 antibodies, IL-1Ra, or anti-TNFbp. SEB-induced
IFN-
was significantly inhibited only by anti-IL-12 antibodies,
indicating that endogenous IL-18, IL-1, and TNF are not required for
SEB-induced IFN-
. In conclusion, the mechanisms of IFN-
stimulation by intact staphylococcal microorganisms and by exotoxins
differ, and this is likely due to the different receptors which are
triggered on the cell membranes. In contrast to its role in the
interactions between staphylococci and host cells, IL-18 does not
appear to play a major role in superantigen-induced IFN-
.
 |
INTRODUCTION |
Sepsis due to gram-positive bacteria
is a life-threatening disease in which the presence of microorganisms
in the bloodstream induces an overwhelming production of
proinflammatory cytokines, such as tumor necrosis factor (TNF),
interleukin-1
(IL-1
), and gamma interferon (IFN-
), which are
thought to play a central role in the pathogenesis of this syndrome
(23). In contrast, in staphylococcal toxic shock syndrome
(TSS), the bacteria rarely invade the host, and the symptoms are caused
by superantigen-induced systemic inflammation. Staphylococcal
components such as lipoteichoic acids (LTA) and peptidoglycans (PG)
(3, 18), as well as the superantigens TSS toxin-1 (TSST-1)
and staphylococcal enterotoxin B (SEB) (16), are believed
to be the main inducers of cytokine production during these two severe illnesses.
LTA and PG are major components of Staphylococcus aureus,
which induces a strong cytokine response (3). These
constituents of the cell wall of most gram-positive bacteria stimulate
monocytes through CD14 and Toll-like receptor 2 (TLR-2) (PG) or TLR-4
(LTA) (5, 28, 31). In contrast, the superantigens TSST-1
and SEB lead to the activation of both lymphocytes and monocytes
through the major histocompatibility complex class II molecules on
antigen-presenting cells and the specific V
elements of the T-cell
receptor (4, 16). Through these two distinct pathways,
macrophages are triggered to produce and release proinflammatory
cytokines, including IL-1, IL-18, TNF-
, and IL-12. IFN-
production likely originates from lymphocytes and natural killer cells
upon secondary stimulation with IL-18 and IL-12 (9).
IL-18, originally described as IFN-
inducing factor
(20), has the ability to induce the synthesis of IL-1
,
TNF-
, IL-8, and chemokines (25), probably through
activation of nuclear factor-
B (17). This places IL-18
in the group of proinflammatory cytokines. IL-18 alone does not induce
significant IFN-
production from T lymphocytes (22),
but in the presence of secondary stimulants, particularly IL-12, IL-2,
mitogens, or microbial agents, large amounts of IL-18-induced IFN-
production are observed (9, 22). Although IL-12 alone is
able to induce IFN-
synthesis, the addition of IL-18 increases this
production severalfold. IL-1, TNF, and IL-18 potentiate the synthesis
of each other, and in turn, they stimulate production of the
second-wave cytokines such as IL-8 and IL-6 (2, 8, 9).
Recently, IL-18 binding protein (IL-18BP), which binds and prevents
IL-18 activity, was described (13, 21).
The aim of the present study was to characterize the cytokine network
induced by whole staphylococcal microorganisms on the one hand and by
the staphylococcal components LTA, PG, TSST-1, and SEB on the other
hand. We have assessed the role of endogenous IL-18, IL-1, TNF, and
IL-12 in the induction of IFN-
, TNF-
, and IL-8 by
Staphylococcus epidermidis and S. aureus, TSST-1, SEB, PG, and LTA in human whole-blood cultures by using specific cytokine inhibitors, such as IL-18BP, IL-1 receptor antagonist (IL-1Ra), TNF-binding protein (TNFbp), and anti-IL-12 antibodies (anti-IL-12 Ab).
 |
MATERIALS AND METHODS |
Volunteer selection.
The study was approved by the Combined
Colorado Investigational Review Board, and each blood donor gave
informed consent. For this study we used whole blood from seven
healthy, nonsmoking volunteers between 23 and 45 years of age. The
volunteers did not report recent infectious or inflammatory disease and
had abstained from using cyclooxygenase inhibitors 2 weeks before the
study. Blood was collected by venipuncture into heparinized tubes
(sodium heparin; final concentration, 20 U/ml; Elkins-Sinn, Cherry
Hill, N.J.). We performed separate replicate experiments (sets of three experiments for each stimulus) and pooled the data to perform the statistics.
Reagents.
RPMI culture medium (Cellgro Mediatech, Herndon,
Va.) was supplemented with 10 mM L-glutamine, 100 U of
penicillin/ml, and 100 µg of streptomycin (Gibco BRL, Grand Island,
N.Y.) per ml. S. epidermidis and S. aureus were
grown in brain heart infusion broth for 24 h, washed in
pyrogen-free saline, and boiled as described previously
(1). The concentration of the heat-killed organisms was
adjusted to 10 per white blood cell. Purified TSST-1, SEB, PG, and LTA
were obtained from Sigma Chemical Co. (St. Louis, Mo.).
Lipopolysaccharide (LPS) contamination of the stimuli used in this
study was excluded in control experiments using polymyxin B
preincubation (2 µg/ml, 2 h) for the various stimuli. Polymyxin B did not alter the cytokine response induced by the various stimuli, demonstrating the absence of LPS contamination.
IL-18BP was expressed in COS cells as the "a" isoform and purified
as a His-tagged protein purified over talon as previously described
(13, 21). Recombinant human IL-1Ra was a kind gift of
Daniel Tracey (Upjohn, Kalamazoo, Mich.). TNFbp (p55 TNF soluble receptor [22]) was a kind gift of Carl Edwards (Amgen, Boulder, Colo.). Murine anti-human IL-12 Ab (clone 11.5.14) was kindly supplied
by Genetics Institute (Cambridge, Mass.).
Whole-blood cultures.
One-half of a milliliter of either
RPMI culture medium or RPMI containing S. epidermidis,
TSST-1, SEB, or LTA in the presence of the various specific inhibitors
(IL-18BP, IL-1Ra, TNFbp, and anti-IL-12 Ab) was added to 12- by 75-mm
round-bottom polypropylene tubes (Falcon; Becton Dickinson Labware,
Franklin Lakes, N.J.), and 0.5 ml of blood was added. The loosely
capped tubes were incubated at 37°C (5% CO2) in an
upright position. After 24 h of incubation, the blood was mixed by
rapid vortexing and 0.5 ml was transferred into 1.5-ml Eppendorf tubes
(Brinkmann Instruments, Westbury, N.Y.). Triton X-100 (Bio-Rad
Laboratories, Richmond, Calif.) was then added (1% final
concentration), and the blood was mixed until lysed. The remaining 0.5 ml of blood was incubated for an additional 24 h, mixed by rapid
vortexing, and lysed with Triton X-100. The lysed blood was stored at
70°C until used for the assay. In these studies, intracellular and
secreted cytokine concentrations were determined together and the
results represent total cytokine production (26).
Cytokine assays.
Measurements of IFN-
, IL-8, and TNF-
were performed by electrochemiluminescence as previously described
(25, 26). The detection limit of the IFN-
assay was 62 pg/ml and of the IL-8 and TNF-
assays was 40 pg/ml.
Statistical analysis.
Data were expressed as means ± standard errors of the means (SEM). Differences between groups were
analyzed with the Wilcoxon test (double sided). The significance of the
dose-response inhibitory effects presented in Fig. 1A was analyzed by
the Kruskal-Wallis test.
 |
RESULTS |
Staphylococcus spp.-induced IFN-
production in whole
blood.
Human whole blood stimulated with heat-killed S. epidermidis induced significant amounts of IFN-
, and this
production was inhibited by IL-18BP in a dose-dependent manner (Fig.
1A). In addition to IL-18BP, anti-IL-12
Ab and TNFbp were also able to inhibit S. epidermidis-induced IFN-
, whereas IL-1Ra did not have a
significant effect (Fig. 1B). No effect of IL-18BP, IL-1Ra, TNFbp, or
anti-IL-12 Ab on S. epidermidis-induced synthesis of IL-8
was apparent (data not shown). Similarly, IFN-
production induced by
S. aureus was significantly inhibited by IL-18BP (67%; P < 0.05) and TNFbp (44%; P < 0.05)
but not by IL-1Ra (9%; P > 0.05).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
S. epidermidis-induced IFN- production in
whole blood. Whole blood was stimulated with S. epidermidis
(10:1 ratio of organisms to leukocytes) in the absence or in the
presence of various concentrations of IL-18BP (A) or with fixed amounts
of IL-18BP (125 ng/ml), IL-1Ra (10 µg/ml), TNFbp (10 µg/ml), or
anti-IL-12 Ab (2.5 µg/ml) (aIL-12) (B). After 48 h the culture
was assayed for IFN- . The amount of IFN- induced by S. epidermidis was set at 100% for each donor and the percent change
(mean ± SEM) for each condition is shown. A 100% S. epidermidis stimulation represents 11.1 ± 2.5 ng of IFN- /ml.
*, P < 0.05 versus S. epidermidis alone
(n = 7 donors).
|
|
Induction of IFN-
, TNF-
, and IL-8 by TSST-1, SEB, PG, and LTA
in whole-blood cultures.
The stimulation of whole blood with
TSST-1 resulted in a marked stimulation of IFN-
(47 ± 24 ng/ml), TNF-
(240 ± 53 pg/ml), and IL-8 (25 ± 6 ng/ml),
corresponding to a 29-, 10-, and 26-fold increase over unstimulated
cultures, respectively. SEB stimulation led to the production of
IFN-
(143 ± 55 ng/ml), TNF-
(459 ± 89 pg/ml), and
IL-8 (66 ± 12 ng/ml), with a 48-, 37-, and 43-fold increase over
unstimulated cultures, respectively. LTA also induced TNF-
(139 ± 73 pg/ml) and IL-8 (52 ± 27 ng/ml), corresponding to a 12- and
38-fold increase over unstimulated cultures, respectively. However,
IFN-
concentrations after LTA stimulation were below the detection
limit (n = seven donors). PG induced significant amounts of IFN-
(49 ± 19 pg/ml) and IL-8 (417 ± 108 pg/ml),
representing a 9- and 23-fold increase over unstimulated cells.
Role of endogenous cytokines in TSST-1-induced cytokine
production.
As shown in Fig. 2A, in
the presence of IL-18BP or IL-1Ra, there was a nonsignificant reduction
in IFN-
levels. However, the combination of both IL-18BP and IL-1Ra
reduced the IFN-
level by 47% (P < 0.05).
Similarly, anti-IL-12 Ab reduced the IFN-
level by 39% and the
combination of anti-IL-12 Ab plus IL-18BP inhibited IFN-
by 49%
(P < 0.05). The addition of TNFbp or the combination
of TNFbp and IL-18BP to the whole-blood culture did not affect IFN-
production (data not shown).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 2.
TSST-1-induced IFN- and IL-8 production in whole
blood. Whole blood was stimulated with TSST-1 (1.5 µg/ml) in the
absence or in the presence of IL-18BP (125 ng/ml), IL-1Ra (10 µg/ml),
or anti-IL-12 Ab (2.5 µg/ml) (aIL-12). After 24 h the culture was
assayed for IL-8 (B), and after 48 h it was assayed for IFN-
(A). The amount of either IL-8 or IFN- induced by TSST-1 was set at
100% for each donor and the percent change (mean ± SEM) for each
condition is shown. A 100% TSST-1 stimulation represents 47 ± 24 ng/ml (IFN- ) and 25 ± 6 ng/ml (IL-8). *, P < 0.05 versus TSST-1 alone (n = 7 donors).
|
|
IL-8 production was not reduced by any of the cytokine inhibitors. In
contrast, neutralizing IL-12 resulted in a significant increase in IL-8
production (85% increase of TSST-1 production; P < 0.05) (Fig. 2B). Although this increase was smaller in the presence of both anti-IL-12 Ab and IL-18BP, IL-8 levels were still greater than with TSST-1 alone (31% increase of TSST-1 production; P < 0.05) (Fig. 2B). The addition of IL-1Ra or TNFbp
or the combination of either IL-1Ra or TNFbp plus IL-18BP to the whole
blood culture did not decrease IL-8 production (data not shown). IL-1Ra
suppressed TSST-1-induced TNF-
production by 25% (P > 0.05), and the combination of IL-1Ra and IL-18BP did not have an
additional effect on TNF-
production. Neutralizing IL-18 and IL-12
did not influence TSST-1-induced TNF-
production (data not shown).
Role of endogenous cytokines in SEB-induced cytokine
production.
As shown in Fig. 3A,
only anti-IL-12 Ab significantly inhibited IFN-
production (40% of
SEB-induced IFN-
production [P < 0.05]). IL-18BP
did not decrease IFN-
and the combination of anti-IL-12 Ab and
IL-18BP was less effective than anti-IL-12 Ab. Blocking IL-1 receptors
also had no effect on SEB induction of IFN-
(data not shown).
Neutralization of TNF-
by TNFbp either alone or in combination with
IL-18BP also had no effect (data not shown).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 3.
SEB-induced IFN- and IL-8 production in whole blood.
Whole blood was stimulated with SEB (2 µg/ml) in the absence or in
the presence of IL-18BP (125 ng/ml), TNFbp (10 µg/ml), or anti-IL-12
Ab (2.5 µg/ml) (aIL-12). After 24 h the culture was assayed for IL-8
(B), and after 48 h it was assayed for IFN- (A). The amount of
either IL-8 or IFN- induced by SEB was set at 100% for each donor
and the percent change (mean ± SEM) for each condition is shown.
A 100% SEB stimulation represents 143 ± 55 ng/ml (IFN- ) and
66 ± 12 ng/ml (IL-8). *, P < 0.05 versus SEB
alone (n = 6 donors).
|
|
IL-8 production was strongly decreased by TNFbp (53%; P < 0.05). The combination of IL-18BP and TNFbp did not reduce IL-8 any further. In fact, the neutralization of IL-18 and TNF led to less
inhibition of SEB-induced IL-8 (28%; not significant). In contrast,
blocking IL-12 had a significant stimulating effect on SEB-induced IL-8
production (52%; P < 0.05) (Fig. 3B). IL-18BP had no
effect on SEB-induced IL-8. The addition of IL-1Ra or the combination
of IL-1Ra and IL-18BP did not affect IL-8 production (data not shown).
TNF-
concentrations in whole blood were not influenced by
neutralizing IL-18, IL-1, or IL-12 (data not shown), indicating that
TNF-
synthesis by SEB is independent of these cytokines.
Role of endogenous cytokines in LTA- and PG-induced cytokine
production.
In contrast to the production of TNF-
and IL-8, LTA
did not induce significant production of IFN-
in whole blood.
LTA-induced IL-8 was significantly inhibited by IL-1Ra (55%;
P < 0.01). The combination of IL-18BP plus IL-1Ra
resulted in a 69% decrease of IL-8 (P < 0.05) (Fig.
4). The addition of TNFbp or anti-IL-12 Ab or the combination of either TNFbp or anti-IL-12 Ab and IL-18BP to
the whole-blood culture did not decrease IL-8 production (data not
shown). TNF-
production was not modulated by neutralizing endogenous
IL-18 and IL-1, although a trend towards increased production was
measured when anti-IL-12 Ab alone or IL-18BP and anti-IL-12 Ab were
added together (59% versus LTA production; P > 0.05)
(data not shown).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 4.
LTA-induced IL-8 production in whole blood. Whole blood
was stimulated with LTA (2 µg/ml) in the absence or in the presence
of IL-18BP (125 ng/ml) or IL-1Ra (10 µg/ml). After 24 h the
culture was assayed for IL-8. The amount of IL-8 induced by LTA was set
at 100% for each donor and the percent change (mean ± SEM) for
each condition is shown. A 100% LTA stimulation represents 52 ± 27 ng of IL-8/ml. *, P < 0.05 versus LTA alone
(n = 6 donors).
|
|
PG-induced production of IFN-
was significantly inhibited by IL-18BP
(58% ± 19%; P < 0.05), IL-1Ra (61% ± 5%;
P < 0.05), and TNFbp (77% ± 13%; P < 0.05). Combination of IL-18BP with both IL-1Ra and TNFbp further
reduced the IFN-
production to less than 5% (P < 0.01). In contrast, IL-18BP and TNFbp had no effects on PG-induced
IL-8 synthesis (P > 0.05; n = 5), and
only IL-1Ra had a moderate, but significant, inhibitory effect (43% ± 17%; P < 0.05).
 |
DISCUSSION |
As previously reported in the literature, both whole
staphylococcal microorganisms and the staphylococcal antigens LTA, PG, TSST-1, and SEB are potent stimuli of TNF, IFN-
, and IL-8 production (3, 16, 32). Only cell-associated IL-18 could be measured after stimulation of cells with the various stimuli (not shown), suggesting that either cell-associated IL-18 is responsible for the
biological effects or that small, undetectable amounts of IL-18 act in
a paracrine or autocrine manner to exert its effects. In our
experiments, whereas S. epidermidis- and S. aureus-induced IFN-
production was strongly reduced by IL-18BP,
anti-IL-12 Ab, and TNFbp, only anti-IL-12 Ab decreased SEB-induced and
TSST-1-induced IFN-
. Even the effect of anti-IL-12 Ab was much less
pronounced for the superantigen-stimulated IFN-
than for S. epidermidis stimulation, and IL-18BP, TNFbp, and IL-1Ra had no
effects. It is therefore apparent that the cytokine pathways leading to
IFN-
induction by intact microorganisms and superantigens are
different. In contrast to Staphylococcus-induced IFN-
synthesis, the IFN-
production induced by SEB and TSST-1 was not
reduced by IL-18BP, indicating that endogenous IL-18 does not play a
central role in superantigen-induced IFN-
. We summarized these
results in Table 1. Our data are in line
with those of Lauw and colleagues showing no effect of anti-IL-18 Ab in
an SEB model of TSS in mice (Lauw et al., unpublished data).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Differential roles of IL-18, IL-12, IL-1, and TNF for
the induction of IFN- by staphylococcal cell wall components and
superantigens
|
|
The importance of Staphylococcus-induced cytokine production
is emphasized by the severity of the two clinical syndromes caused by
staphylococcal infections in which the systemic inflammation caused by
overwhelming cytokinemia is thought to play a pivotal role:
Staphylococcus sepsis and TSS (7). Whereas in
the former the cytokine release is triggered by invasion of the
circulation by intact microorganisms, in the latter the staphylococci
rarely invade the host and the cytokine production is triggered by
exotoxins acting as superantigens. In the present study, we
investigated whether the cytokine network induced by either intact
S. aureus and S. epidermidis microorganisms or
the staphylococcal superantigens is divergent.
Several cytokines are known to be involved in IFN-
production,
either directly or following costimulation with other cytokines or
microbial agents. An important role for IFN-
induction was attributed to endogenous IL-18. Reduction of LPS-induced IFN-
in
IL-1
-converting enzyme-deficient macrophages lacking a functional IL-18 can be greater than 90%, despite normal levels of IL-12 (10, 11, 30), a cytokine which appears to be essential for IFN-
production (15). IL-12, produced by phagocytic
cells in response to bacteria, is able to induce IFN-
production by
natural killer and T cells (27). Two mechanisms may
account for the stimulatory effects of IL-12 on IFN-
production.
First, IL-12 upregulates production of IL-18 (14), and
second, IL-12 increases the responsiveness of T and B cells to IL-18 by
up-regulation of IL-18 receptor expression (34). In
addition to IL-12 and IL-18, other cytokines important for the
induction of IFN-
are IL-1 and TNF, which potentiate IFN-
production together with IL-12 (6, 29, 33). In the present
study we show that stimulation of human whole blood with heat-killed
Staphylococcus spp. induces the release of IFN-
in an
IL-18-, IL-12-, and TNF-dependent manner. This is probably due to
effects exerted at the level of PG stimulation of cytokine synthesis,
as similar effects of the cytokine inhibitors were seen when cells were
incubated with PG. In contrast, TSST-1- and SEB-induced IFN-
production is not significantly reduced by IL-18BP, TNFbp, and IL-1Ra,
whereas it is slightly inhibited by anti-IL-12 Abs.
Differences were also apparent when production of the chemokine IL-8
was assessed: direct IL-8 stimulation by intact microorganisms and at
least partial dependency of IL-8 production on endogenous TNF in the
case of SEB were observed. In addition, the TNF production was not
inhibited by any of the cytokine inhibitors used, confirming the
proximal place of TNF in the cytokine cascade.
The differences between the cytokine patterns induced either by intact
staphylococci or by staphylococcal exotoxins are probably mediated by
the differential receptors they stimulate on the cell membranes to
trigger cytokine synthesis. The gram-positive microorganisms are
recognized by pattern recognition receptors such as TLR-2 and TLR-6 on
the cell membrane (24, 28, 31), and CD14 can facilitate
this process (5). Gram-positive components such as LTA
have been suggested to be involved, but LTA did not stimulate IFN-
synthesis, possibly due to the absence of alanine substituents lost in
the purification procedures (19). In contrast,
staphylococcal PG strongly stimulated IFN-
synthesis and play a
pivotal role in TLR-2- and CD14-mediated cytokine induction by
Staphylococcus spp. (24, 31). Disintegration of
the microorganisms and release of bacterial DNA, which would stimulate
monocytes through TLR-9, are also likely to be important
(12).
In contrast to this pathway, the staphylococcal exotoxins TSST-1 and
SEB induce proliferation of T cells through direct binding to the major
histocompatibility complex class II molecules on antigen-presenting
cells and through stimulation of T-cell receptor-specific V
elements. This pathway leads to the induction of proinflammatory cytokines (3-5). Our observation that TSST-1 and SEB
induce IFN-
, TNF-
, and IL-8 is consistent with previous studies
(8-10). Several investigators have reported that direct
contact is needed between monocytes and T cells to induce TNF-
and
IL-1
by superantigens (25, 26). In contrast, other
reports show the release of IL-1, TNF-
, and IL-6 in response to
TSST-1 and SEB by monocytes in the absence of T cells (9, 10, 27,
28). In whole-blood cultures, contact between monocytes and T
cells likely takes place. This pathway of IFN-
stimulation appears
to be independent of endogenous IL-18, TNF, and IL-1 and only
marginally dependent on IL-12.
In conclusion, Staphylococcus microorganisms and the
staphylococcal exotoxins TSST-1 and SEB are potent stimuli of IFN-
, TNF-
, and IL-8 production. However, the cytokine pathways leading to
production of IFN-
and IL-8 by these stimuli are different, and this
is likely due to differential receptors which are recognized and
triggered on the cell membranes. These differences may in part explain
the clinical differences between staphylococcal sepsis and
staphylococcal TSS.
 |
ACKNOWLEDGMENTS |
This study was partly supported by NIH grant AI-15614 (to
C.A.D.). M.G.N. was supported by a grant from Stichting "De Drie Lichten," Leiden, The Netherlands.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medicine (541), University Medical Center St. Radboud, Geert
Grooteplein 8, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Phone:
31-24-3614652. Fax: 31-24-3541734. E-mail:
M.Netea{at}aig.azn.nl.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Aiura, K.,
J. A. Gelfand,
J. F. Burke,
R. C. Thompson, and C. A. Dinarello.
1993.
Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 in rabbits.
Infect. Immun.
61:3342-3350[Abstract/Free Full Text].
|
| 2.
|
Beutler, B. E.
1992.
Tumor necrosis factors. The molecules and their emerging roles in medicine.
Raven Press, New York, N.Y.
|
| 3.
|
Bhakdi, S.,
T. Klonisch,
P. Nuber, and W. Fisher.
1991.
Stimulation of monokine production by lipoteichoic acids.
Infect. Immun.
59:4616-4620.
|
| 4.
|
Choi, Y.,
B. Kotzin,
L. Hernon,
J. Callahan,
P. Marrack, and J. Kappler.
1989.
Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.
Proc. Natl. Acad. Sci. USA
86:8941-8945[Abstract/Free Full Text].
|
| 5.
|
Cleveland, M. G.,
J. D. Gorham,
T. L. Murphy,
E. Tuomanen, and K. M. Murphy.
1996.
Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway.
Infect. Immun.
64:1906-1912[Abstract].
|
| 6.
|
D'Andrea, A.,
M. Aste-Amezaga,
N. M. Valiante,
M. Xiaojing,
M. Kubin, and G. Trinchieri.
1993.
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
J. Exp. Med.
178:1041-1048[Abstract/Free Full Text].
|
| 7.
|
Davis, J. P.,
P. J. Chesney,
P. J. Wand, and M. LaVenture.
1980.
Toxic-shock syndrome: epidemiologic features, recurrence, risk factors and prevention.
N. Engl. J. Med.
303:1429-1435[Abstract].
|
| 8.
|
Dinarello, C. A.
1996.
Biologic basis for interleukin-1 in disease.
Blood
87:2095-2147[Abstract/Free Full Text].
|
| 9.
|
Dinarello, C. A.
1999.
IL-18: a Th1-inducing, proinflammatory cytokine and a new member of the IL-1 family.
J. Allergy Clin. Immunol.
103:11-24[CrossRef][Medline].
|
| 10.
|
Ghayur, T.,
S. Banerjee,
M. Hugunin,
D. Butler,
L. Herzog,
A. Carter,
L. Quintal,
L. Sekut,
R. Talanian,
M. Paskind,
W. Wong,
R. Kamen,
D. Tracey, and H. Allen.
1997.
Caspase-1 processes IFN- -inducing factor and regulates LPS-induced IFN- production.
Nature
386:619-623[CrossRef][Medline].
|
| 11.
|
Gu, Y.,
K. Kuida,
H. Tsutsui,
G. Ku,
K. Hsiao,
M. A. Fleming,
N. Hayashi,
K. Higashino,
H. Okamura,
K. Nakanishi,
M. Kurimoto,
T. Tanimoto,
R. A. Flavell,
V. Sato,
M. W. Harding,
D. J. Livingston, and M. S.-S. Su.
1997.
Activation of interferon- inducing factor mediated by interleukin-1 converting enzyme.
Science
275:206-209[Abstract/Free Full Text].
|
| 12.
|
Hemmi, H.,
O. Takeuchi,
T. Kawai,
T. Kaisho,
S. Sato,
H. Sanjo,
M. Matsumoto,
K. Hoshino,
H. Wagner,
K. Takeda, and S. Akira.
2000.
A Toll-like receptor recognizes bacterial DNA.
Nature
408:740-745[CrossRef][Medline].
|
| 13.
|
Kim, S.-H.,
M. Eisenstein,
L. Reznikov,
G. Fantuzzi,
D. Novick,
M. Rubinstein, and C. A. Dinarello.
2000.
Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.
Proc. Natl. Acad. Sci. USA
97:1190-1195[Abstract/Free Full Text].
|
| 14.
|
Lauw, F. N.,
P. E. Dekkers,
A. A. te Velde,
P. Speelman,
M. Levi,
M. Kurimoto,
C. E. Hack,
S. J. van deventer, and T. van der Poll.
1999.
Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees.
J. Infect. Dis.
179:646-652[CrossRef][Medline].
|
| 15.
|
Magram, J.,
S. E. Connaughton,
R. R. Warrier,
D. M. Carvajal,
C. Y. Wu,
J. Ferrante,
C. Stewart,
U. Sarmiento,
D. A. Faherty, and M. K. Gately.
1996.
Interleukin-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses.
Immunity
4:471-481[CrossRef][Medline].
|
| 16.
|
Marrack, P., and J. Kappler.
1990.
The staphylococcal enterotoxins and their relatives.
Science
248:705-711[Abstract/Free Full Text].
|
| 17.
|
Matsumoto, S.,
K. Tsuji-Takayama,
Y. Aizawa,
K. Koide,
M. Takeuchi,
T. Ohta, and M. Kurimoto.
1997.
Interleukin-18 activates NF- B in murine T helper type 1 cells.
Biochem. Biophys. Res. Commun.
234:545-457.
|
| 18.
|
Mattsson, E.,
L. Verhage,
J. Rollof,
A. Fleer,
J. Verhoef, and H. van Dijk.
1993.
Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6.
FEMS Immunol. Med. Microbiol.
7:281-287[Medline].
|
| 19.
|
Morath, S.,
A. Geyer, and T. Hartung.
2001.
Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus.
J. Exp. Med.
193:393-398[Abstract/Free Full Text].
|
| 20.
|
Nakamura, K.,
H. Okamura,
M. Wada,
K. Nagata, and T. Tamura.
1989.
Endotoxin-induced serum factor that stimulates gamma interferon production.
Infect. Immun.
57:590-595[Abstract/Free Full Text].
|
| 21.
|
Novick, D.,
S.-H Kim,
G. Fantuzzi,
L. L. Reznikov,
C. A. Dinarello, and M. Rubinstein.
1999.
Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.
Immunity
10:127-136[CrossRef][Medline].
|
| 22.
|
Okamura, H.,
H. Tsutsui,
T. Komatsu,
M. Yutsudo,
A. Hakura,
T. Tanimoto,
K. Torigoe,
T. Okura,
Y. Nukada,
K. Hattori,
K. Akita,
M. Namba,
F. Tanabe,
K. Konishi,
S. Fukuda, and M. Kurimoto.
1995.
Cloning of a new cytokine that induces interferon- production by T cells.
Nature
378:88-91[CrossRef][Medline].
|
| 23.
|
Okusawa, S.,
J. A. Gelfand,
T. Ikejima,
R. J. Connolly, and C. A. Dinarello.
1988.
Interleukin-1 induces a shock-like state in rabbits.
J. Clin. Investig.
81:1162-1172.
|
| 24.
|
Ozinsky, A.,
D. M. Underhill,
J. D. Fontenot,
A. M. Hajjar,
K. D. Smith,
C. B. Wilson,
L. Schroeder, and A. Aderem.
2000.
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors.
Proc. Natl. Acad. Sci. USA
97:13766-13771[Abstract/Free Full Text].
|
| 25.
|
Puren, A. J.,
G. Fantuzzi,
Y. Gu,
M. S.-S. Su, and C. A. Dinarello.
1998.
Interleukin-18 (IFN inducing factor) induces IL-8 and IL-1 via TNF production from non-CD14+ human mononuclear cells.
J. Clin. Investig.
101:711-721[Medline].
|
| 26.
|
Puren, A. J.,
P. Razeghi,
G. Fantuzzi, and C. A. Dinarello.
1998.
Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures.
J. Infect. Dis.
178:1830-1834[CrossRef][Medline].
|
| 27.
|
Schoenhaut, D. S.,
A. O. Chua,
A. G. Wolitzky,
P. M. Quinn,
C. M. Dwyer,
W. McComas,
P. C. Familetti,
M. K. Gately, and U. Gubler.
1992.
Cloning and expression of murine IL-12.
J. Immunol.
148:3433-3440[Abstract].
|
| 28.
|
Schwandner, R.,
R. Dziarski,
H. Wesche,
M. Rothe, and C. J. Kirschning.
1999.
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.
J. Biol. Chem.
274:17406-17409[Abstract/Free Full Text].
|
| 29.
|
Skeen, M. J., and H. K. Ziegler.
1995.
Activation of  cells for production of IFN- is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12.
J. Immunol.
154:5832-5841[Abstract].
|
| 30.
|
Takeda, K.,
H. Tsutsui,
T. Yoshimoto,
O. Adachi,
N. Yoshida,
K. Kishimoto,
H. Okamura,
K. Nakanishi, and S. Akira.
1998.
Defective NK cell activity and Th1 response in IL-18-deficient mice.
Immunity
8:383-390[CrossRef][Medline].
|
| 31.
|
Takeuchi, O.,
K. Hoshino,
T. Kawai,
H. Sanjo,
H. Takada,
T. Ogawa,
K. Takeda, and S. Akira.
1999.
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.
Immunity
11:443-451[CrossRef][Medline].
|
| 32.
|
Wakabayashi, G.,
J. G. Gelfand,
W. K. Jung,
R. J. Connolly,
J. F. Burke, and C. A. Dinarello.
1991.
Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli.
J. Clin. Investig.
87:1925-1935.
|
| 33.
|
Wherry, J. C.,
R. D. Schreiber, and E. R. Unanue.
1991.
Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli.
Infect. Immun.
59:1709-1715[Abstract/Free Full Text].
|
| 34.
|
Yoshimoto, T.,
K. Takeda,
T. Tanaka,
K. Ohkusu,
S. Kashiwamura,
H. Okamura,
S. Akira, and K. Nakanishi.
1998.
IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
J. Immunol.
161:3400-3407[Abstract/Free Full Text].
|
Infection and Immunity, August 2001, p. 5025-5030, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.5025-5030.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zwijnenburg, P. J. G., van der Poll, T., Florquin, S., Roord, J. J., van Furth, A. M.
(2003). IL-1 Receptor Type 1 Gene-Deficient Mice Demonstrate an Impaired Host Defense Against Pneumococcal Meningitis. J. Immunol.
170: 4724-4730
[Abstract]
[Full Text]
-
Abraham, M., Shapiro, S., Lahat, N., Miller, A.
(2002). The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells. Int Immunol
14: 1449-1457
[Abstract]
[Full Text]
-
Heyer, G., Saba, S., Adamo, R., Rush, W., Soong, G., Cheung, A., Prince, A.
(2002). Staphylococcus aureusagr and sarA Functions Are Required for Invasive Infection but Not Inflammatory Responses in the Lung. Infect. Immun.
70: 127-133
[Abstract]
[Full Text]